ebselen has been researched along with bis(7)-tacrine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Huang, L; Li, X; Luo, Z; Mao, F; Zhou, Q | 1 |
| Alejandre-Ramos, D; Bartolini, M; Bolognesi, ML; Fernández-Bolaños, JG; Lagunes, I; López, Ó; Maya, I; Monti, B; Padrón, JM; Peña-Altamira, LE; Roldán-Peña, JM | 1 |
2 other study(ies) available for ebselen and bis(7)-tacrine
| Article | Year |
|---|---|
Novel tacrine-ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity.
Topics: Acetylcholinesterase; Animals; Azoles; Binding Sites; Butyrylcholinesterase; Cell Line; Cell Survival; Cholinesterase Inhibitors; Free Radical Scavengers; Horses; Humans; Hydrogen Peroxide; Isoindoles; Kinetics; Molecular Docking Simulation; Organoselenium Compounds; Peroxynitrous Acid; Protein Binding; Protein Structure, Tertiary; Tacrine | 2013 |
New tacrine dimers with antioxidant linkers as dual drugs: Anti-Alzheimer's and antiproliferative agents.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antineoplastic Agents; Antioxidants; Cell Line, Tumor; Cell Proliferation; Chalcogens; Cholinesterase Inhibitors; Dimerization; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Mice; Molecular Structure; Organoselenium Compounds; Peptide Fragments; Protein Aggregates; Structure-Activity Relationship; Tacrine | 2017 |